ArticleBlood advances2026

Early steroid and anakinra use to manage axicabtagene ciloleucel toxicity reduces the total duration of CRS and ICANS.

William L Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.